As of November 2024, Syndax Pharmaceuticals has a market cap of $1.53B. This makes Syndax Pharmaceuticals the world's 6111th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.89B | 3.15% |
2023 | $1.83B | -15.09% |
2022 | $2.16B | 16.26% |
2021 | $1.86B | -1.57% |
2020 | $1.89B | 153.30% |
2019 | $744.63M | 97.30% |
2018 | $377.40M | -49.20% |
2017 | $742.93M | 22.18% |
2016 | $608.09M | - |